We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$457M
AUM Growth
+$26.6M
Cap. Flow
+$8.53M
Cap. Flow %
1.86%
Top 10 Hldgs %
38.17%
Holding
99
New
16
Increased
39
Reduced
27
Closed
17

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$16.5M
2
RGEN icon
Repligen
RGEN
+$7.52M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$6.71M
4
NVRO
NEVRO CORP.
NVRO
+$5.59M
5
DXCM icon
DexCom
DXCM
+$4.89M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.2M
2
VCEL icon
Vericel Corp
VCEL
+$5.11M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$4.72M
4
ARWR icon
Arrowhead Research
ARWR
+$4.65M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$4.27M

Sector Composition

Rank Sector Weight
1 Healthcare 95.62%
2 Technology 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASLN
76
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$745K 0.16%
5,647
-2,478
-30% -$310K
AUPH icon
77
Aurinia Pharmaceuticals
AUPH
$2.06B
$648K 0.14%
49,969
+388
+0.8% +$4.94K
WHWK
78
Whitehawk Therapeutics
WHWK
$269M
$598K 0.13%
23,597
-43,149
-65% -$986K
VSTM icon
79
Verastem
VSTM
$629M
$512K 0.11%
+10,483
New +$437K
AMAM
80
DELISTED
Ambrx Biopharma Inc
AMAM
$294K 0.06%
+15,000
New +$256K
KPRX icon
81
Kiora Pharmaceuticals
KPRX
$11.7M
$275K 0.06%
210
+1
+0.5% +$1.55K
CALA
82
DELISTED
Calithera Biosciences, Inc
CALA
$210K 0.05%
+5,031
New +$221K
AMGN icon
83
Amgen
AMGN
$225B
– –
-45,059
Closed -$11.2M
ARWR icon
84
Arrowhead Research
ARWR
$12.3B
– –
-70,089
Closed -$4.65M
ATEC icon
85
Alphatec Holdings
ATEC
$1.49B
– –
-100,000
Closed -$1.58M
BFLY icon
86
Butterfly Network
BFLY
$2.52B
– –
-30,315
Closed -$510K
CRIS icon
87
Curis
CRIS
$3.49M
– –
-490
Closed -$2.22M
HAE icon
88
Haemonetics
HAE
$4.16B
– –
-17,500
Closed -$1.94M
JAZZ icon
89
Jazz Pharmaceuticals
JAZZ
$16.2B
– –
-15,000
Closed -$2.47M
KALA icon
90
KALA BIO
KALA
$17.1M
– –
-59
Closed -$1M
KNSA icon
91
Kiniksa Pharmaceuticals
KNSA
$6.1B
– –
-80,603
Closed -$1.49M
PHAT icon
92
Phathom Pharmaceuticals
PHAT
$742M
– –
-30,207
Closed -$1.14M
PROF
93
Profound Medical
PROF
$252M
– –
-84,399
Closed -$1.7M
QQQ icon
94
PUT
Invesco QQQ Trust
QQQ
$481B
– –
-50,000
Closed -$16M
RAPT
95
DELISTED
RAPT Therapeutics
RAPT
– –
-5,046
Closed -$896K
SILK
96
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-20,000
Closed -$1.01M
ONEM
97
DELISTED
1Life Healthcare
ONEM
– –
-45,217
Closed -$1.77M
TPTX
98
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-13,962
Closed -$1.32M
NUAN
99
DELISTED
Nuance Communications, Inc.
NUAN
– –
-91,173
Closed -$3.98M
1 2 3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Parkman Healthcare Partners held 99 positions worth $457M, up 6.2% from $431M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Parkman Healthcare Partners's Q2 2021 filing shows 16 new, 39 increased, 27 reduced and 17 closed positions. Its largest new stake was Intuitive Surgical: 58,839 shares worth $18M. The largest sale was Amgen, an estimated $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 92% a quarter earlier, followed by Technology.

  • Parkman Healthcare Partners's largest Q2 2021 buy was Intuitive Surgical: 58,839 shares worth $18M.
  • Parkman Healthcare Partners added most to DexCom in Q2 2021, an estimated $4.89M increase.
  • Parkman Healthcare Partners's biggest Q2 2021 reduction was Vericel Corp, cutting an estimated $5.11M.
  • Parkman Healthcare Partners fully exited Amgen in Q2 2021, selling an estimated $11.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 38% of its $457M portfolio in Q2 2021.
  • Parkman Healthcare Partners opened 16 new positions and closed 17 in Q2 2021.
  • Parkman Healthcare Partners's portfolio value rose 6.2% quarter-over-quarter to $457M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2021, filed 13 Aug 2021.